Valneva (VALN) announced results for its Phase 2 clinical trial evaluating the safety and immunogenicity of two different ...

Whilst vaccines exist for animals, none are commercially available for human use for the mosquito-borne virus.

Vaxxas Pty. Ltd. and the Coalition for Epidemic Preparedness Innovations are progressing heat-stable, dried-formulation mRNA ...

Vaxxas and CEPI advance US$ 4.8 million programme for needle-free thermostable mRNA vaccines: Cambridge, Massachusetts Friday, January 24, 2025, 14:00 Hrs [IST] Vaxxas, a clinical ...

VIDO's funding flows from Norwegian-based Coalition for Epidemic Preparedness Innovations (CEPI) into its ongoing development of its pan-sarbecovirus vaccine. Dr. Nicole Lurie, Executive Director of ...

Clinical-stage Australian biotechnology company Vaxxas will receive $3.2 million from the US Biomedical Advanced Research and ...

Gates was in Davos to promote a new global health security initiative – The Coalition for Epidemic Preparedness Innovations or CEPI. Follow BI Video: On Twitter More from News Bill Gates ...

Brisbane-based biotechnology company Vaxxas has secured approval from Coalition for Epidemic Preparedness Innovation (CEPI) ...

The Saskatoon-based organization recently received a $24 million grant from the Coalition for Epidemic Preparedness ...

VIDO's funding flows from Norwegian-based Coalition for Epidemic Preparedness Innovations (CEPI) into its ongoing development of its pan-sarbecovirus vaccine. Dr. Nicole Lurie, Executive Director ...